by Mark Curtis | Mar 11, 2014
. Welcome to your update from the clinic for the month of February! OncoMed is the leader in news this month with various Phase 1b trials for its cancer stem cell-targeting fusion protein. Immunocellular Therapeutics and StemCells Inc. file orphan drug designations...
by Roshan Yoganathan | Mar 7, 2014
. I’m not sure many of you are die-hard biomaterial fans like me, but there was a shot heard around the biomaterial world when Canada’s very own Professor Michael Sefton, at the University of Toronto, proposed creating a heart in a box. He made the claim nearly ten...
by Stacey Johnson | Feb 21, 2014
. Dr. Robert Langer’s enthusiasm for the limitless promise of bioengineering is infectious. With his efforts and under his tutelage, one hopes that huge advances will be made in restoring movement to the paralyzed and curing the sick through, for example, more...
by Roshan Yoganathan | Feb 18, 2014
. This past weekend I was watching the Superbowl, along with millions of North Americans,not to see the Seahawks beat down the Broncos, but for all the must-see million dollar commercials. The one commercial that stood out to me was the Geico commercial with the...
by Mark Curtis | Feb 11, 2014
. Welcome to your Regenerative Medicine Deal Review for the month of January! There was lots of flow in January, including yet another research collaboration from Cellular Dynamics International – this time with the Nestle Institute of Health Sciences to use the...
by Mark Curtis | Feb 4, 2014
. Welcome to your Update from the Clinic for the month of January! We start the year off with the German health authority approving Pluristem’s next generation GMP cell manufacturing facility. Neuralstem successfully, and safely, transplants NSI-556 cells directly...
Comments